Aminolevulinic Acid (ALA)

ALA + Light-Based Treatments = Combination for Success

Photodynamic Therapy, the concept of using a photosensitizing compound in conjunction with light therapy to provide localized destruction of specific targets, has been utilized in some form since 1400 B.C. More recently, companies such as Dusa Pharmaceuticals have explored using these compounds on a variety of conditions such as acne vulgaris, actinic keratosis, and a wide variety of dermatological applications to master their results. In 1999, Dusa Pharmaceuticals achieved the first FDA approval of Aminolevulinic Acid (ALA) for the treatment of actinic keratosis. As evidence has been noted for the therapeutic efficacy of other conditions including acne vulgaris and photorejuvenation, ALA's future keeps getting brighter.

What effects will this have on your practice? Imagine the possibilities of treating aggressive forms of acne without antibiotics, improving the results of already effective light-based treatments, or achieving success for conditions that lie in the junction between medical dermatology and cosmetic dermatology.

In aesthetics, you will find that combination therapies will often provide you with greater results than any one therapy could provide on its own. As a supportive therapy that delivers, safe, effective, relatively pain-free results, without significant adverse effects, ALA can represent an impressive addition to your phototherapy results. Call AAC now at 800-337-0745 to let us show you how ALA can effectively compliment your aesthetic practice today.

	Applications
	Acne
	Anti-Aging / Wrinkle Reduction
	Skin Discoloration (Pigmentation)

Request more information now.